[ORGANIZATION]
anti‑PD‑L1 antibody
Featured in 1 tracked story · first seen
Situations
Israeli Alzheimer’s Immunotherapy Trials
2 clusters · 5 sources · last updated
Latest: Anti-PD-L1 Antibody IBC‑Ab002 Shows Safety in Early Alzheimer’s Phase 1b Trial
An Israeli‑developed immune therapy, IBC‑Ab002, progressed through early clinical testing for Alzheimer’s disease. The first-in‑human Phase 1 trial, conducted by the Weizmann Institute, demonstrated a favorable safety pr